Phibro Animal Health | PAHC - 债务利息支出

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 240.42M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 332.36M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 603.6M

USD 2.06B

USD 27.46M

USD 332.36M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 215.87M

	债务利息支出	更改		日
Align Technology	USD 2M		660K	2023-03
ANI Pharmaceuticals	USD 4.41M		316K	2025-12
Assertio Holdings	USD 758K		1000	2024-06
Aurora Cannabis	CAD 2.11M		116K	2025-12
Bristol-Myers Squibb	USD 432M		48M	2025-12
Canopy Growth	CAD 7.34M		1.46M	2025-12
Corcept Therapeutics	USD 823.61M		21.88M	2025-09
Eli Lilly	USD 114.7M		134.3M	2025-09
Henry Schein	USD 39M		1000K	2025-12
Idexx Laboratories	USD 10.08M		1.24M	2025-09
Knight Therapeutics	CAD 3.92M		1.56M	2025-12
Merck	USD 412M		85M	2025-12
Nektar Therapeutics	USD 6.02M		420K	2024-09
Pacira	USD 3.89M		387K	2025-12
Phibro Animal Health	USD 11.91M		191K	2025-12
Prestige Brands	USD 10.67M		636K	2025-12
Supernus Pharmaceuticals	USD 910K		278K	2023-06
Zoetis	USD 57M		1000K	2025-12